Catalog No.
Product Name
Application
Product Information
Citations
-
Purine Nucleoside Analog
8-Chloro-2'-O-methyl adenosine is a purine nucleoside analog that exhibits potent antitumor activity. It primarily targets indolent lymphoid malignancies, utilizing mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research into cancer biology and therapeutic applications targeting malignancies. -
Adenosine Analog
5’-O-(4,4’-Dimethoxytrityl)-3’-O-t-butyldimethylsilyl adenosine is an adenosine analog that serves as a key modulator of adenosine receptors. This compound exhibits vasodilatory effects on smooth muscle and has potential applications in cancer research due to its ability to inhibit tumor progression. It is particularly useful for studies investigating the roles of adenosine in vascular biology and oncology. -
Purine Nucleoside Analog
N4-Benzoyl-7'-OH-N-trityl morpholino cytosine is a purine nucleoside analog that primarily targets DNA synthesis. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and inhibiting cellular proliferation. This compound serves as a valuable tool in cancer research, facilitating the study of mechanisms underlying nucleotide metabolism and potential therapeutic interventions. -
Purine Nucleoside Analog
3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine is a purine nucleoside analog that primarily targets DNA synthesis pathways. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms that include the inhibition of DNA synthesis and the induction of apoptosis. Its applications in chemical research may support the development of novel therapeutic strategies in oncology. -
Cytidine Analog
N4-Benzoyl-5’-O-DMT-3’-O-(2-methoxyethyl)-5-methylcytidine is a cytidine analog that functions as an inhibitor of DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor properties, making it valuable in cancer research. Its unique chemical structure enables investigations into epigenetic modifications and therapeutic approaches targeting DNA methylation pathways. -
Cytidine Analog
2'-Deoxy-2'-fluoro-5-methyl-arabinocytidine is a cytidine nucleoside analog that functions primarily as an inhibitor of DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it valuable in cancer research. It is useful for studying epigenetic regulation and therapeutic strategies targeting methylation-driven processes in various malignancies. -
Purine Nucleoside Analog
2-Chloro-6-(thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily functions by inhibiting DNA synthesis and inducing apoptosis in cancer cells, making it a valuable reagent for research in cancer therapeutics. Its unique structure allows for exploration in pharmacological studies and therapeutic applications targeting nucleoside metabolism. -
Purine Nucleoside Analog
6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine is a purine nucleoside analog that exerts its effects by inhibiting DNA synthesis. This compound demonstrates notable antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action involve the induction of apoptosis and disruption of cellular proliferation, making it a valuable tool for cancer research. -
Adenosine Analog
2-Amino-N6,N6-dimethyl-2’-O-methyladenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits smooth muscle vasodilatory effects and has potential applications in inhibiting cancer progression. It is valuable for research in cardiovascular studies and oncology, providing insights into the therapeutic potential of adenosine-related pathways. -
Purine Nucleoside Analog
6-Methylpseudouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its biological mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for studies focused on cellular proliferation and apoptosis pathways in neoplastic cells. -
Adenosine Analog
3’-beta-C-Methyl-N6-methyladenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant smooth muscle vasodilatory effects and has demonstrated potential in inhibiting cancer progression. Its unique structure allows for various research applications, particularly in studies focusing on cardiovascular function and tumor biology. -
Purine Nucleoside Analog
8-Amino-2′-deoxyadenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound in cancer research. This reagent is suitable for exploring therapeutic strategies in nucleotide metabolism and evaluating potential treatments for lymphoid cancers. -
Cytidine Analog
5-Vinylcytidine is a cytidine analog that functions primarily as an inhibitor of DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it valuable in cancer research and therapeutic investigations. Its ability to alter epigenetic modifications positions it as a useful tool for studying gene regulation and methylation patterns in various biological contexts. -
Purine Nucleoside Analog
2'-Amino-2'-deoxy-5-fluoro-arabinouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action involve the inhibition of DNA synthesis and the induction of apoptosis. This reagent is valuable for research in cancer biology and the development of novel therapeutic agents targeting nucleoside metabolism. -
Purine Nucleoside Analog
5-Methyl-4'-thiocytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research by helping to elucidate the molecular pathways involved in tumor growth and resistance. -
Purine Nucleoside Analog
3',5'-Bis-O-benzoyl-2'-deoxy-2'-fluoro-4-deoxy-arabinouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its biological mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies focusing on nucleoside metabolism and the development of novel therapeutic strategies in oncology. -
Purine Nucleoside Analog
2-Amino-6-allyl thio-9-(beta-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound serves as a valuable tool for research applications focusing on cancer treatment strategies and the exploration of nucleoside analogs in therapeutic development. -
Purine Nucleoside Analog
2-Amino-2’,3’-bis-O-(2-methoxyethyl) adenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer treatment and the exploration of nucleoside analogs in therapeutic development. -
Purine Nucleoside Analog
2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-methyluridine is a purine nucleoside analog with significant antitumor properties, specifically against indolent lymphoid malignancies. Its biological activity involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound in cancer research. This reagent can be utilized to explore mechanisms of action in cancer therapy and to evaluate its potential in drug development. -
Purine Nucleoside Analog
N2-Ethylguanosine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. This compound exerts its anticancer effects through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. It serves as a valuable tool for research applications focused on cancer therapeutics and the study of nucleoside biochemistry. -
Purine Nucleoside Analog
2′-β-C-Methyl isoguanosine is a purine nucleoside analog that primarily targets nucleic acid synthesis pathways. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA synthesis and inducing apoptosis in cancer cells. Its application in cancer research facilitates the exploration of therapeutic strategies for treating resistant forms of hematological malignancies. -
Purine Nucleoside Analog
2-Methyl-2’-deoxyadenosine is a purine nucleoside analog that exerts cytotoxic effects by inhibiting DNA synthesis. This compound is primarily investigated for its antitumor activity against indolent lymphoid malignancies. Its mechanisms of action include the induction of apoptosis and disruption of cellular proliferation, making it relevant for cancer research applications. -
Purine Nucleoside Analog
2-Methylthio isopentenyladenosine is a purine nucleoside analog that exhibits notable antitumor activity, particularly against indolent lymphoid malignancies. This compound functions primarily by inhibiting DNA synthesis and inducing apoptosis in cancer cells. Its unique mechanism makes it a valuable tool for research into cancer therapies and mechanisms of cellular proliferation. -
Purine Nucleoside Analog
3′-Deoxy-3′-iodothymidine is a purine nucleoside analog that primarily targets DNA synthesis. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by interfering with nucleotide metabolism and inducing apoptotic pathways in cancer cells. This compound serves as an essential tool for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
3’,5’-Di-O-benzoyl-2’-deoxy-2’-fluoro-5-methyl-β-D-arabino-uridine is a purine nucleoside analog known for its antitumor activity. This compound targets indolent lymphoid malignancies through mechanisms that include the inhibition of DNA synthesis and the induction of apoptosis. Its unique structural modifications enhance its efficacy in cancer research applications. -
Purine Nucleoside Analog
2'-Deoxy-N6-phenoxyacetyladenosine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic applications. This reagent is essential for studies focusing on the development of novel anticancer strategies and understanding the molecular pathways involved in tumorigenesis. -
Purine Nucleoside Analog
2’-Deoxy-2’-fluoro-arabino-tubercidine is a purine nucleoside analogue that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound serves as an important reagent for studying the pharmacological effects of purine analogs in therapeutic applications. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-5-methylcytidine is a purine nucleoside analog that demonstrates significant antitumor activity by targeting indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies investigating therapeutic strategies in oncology and the molecular mechanisms underlying lymphoid malignancies. -
Purine Nucleoside Analog
6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside is a purine nucleoside analog that exhibits notable antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for studying cancer biology and therapeutic interventions. This compound provides a critical tool for researchers investigating the effects of purine analogs in cancer treatment. -
Purine Nucleoside Analog
5-Bromo-2'-O-methyluridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action primarily involves the inhibition of DNA synthesis and the induction of apoptosis. This compound is useful in cancer research for exploring therapeutic strategies targeting nucleoside metabolism and cancer cell proliferation. -
Purine Nucleoside Analog
3′-Chloro-3′-deoxy-5′-O-(triphenylmethyl)thymidine is a purine nucleoside analog that targets DNA synthesis. It exhibits significant antitumor activity against indolent lymphoid malignancies through mechanisms such as the inhibition of DNA replication and the induction of apoptosis. This compound is useful in cancer research and therapeutic studies focused on lymphoid malignancies. -
Adenosine Analog
2’-O-Propargyladenosine is an adenosine analog that serves as a versatile click chemistry reagent due to its unique alkyne group. This compound exhibits smooth muscle vasodilatory effects and demonstrates potential for inhibiting cancer progression. Its ability to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) makes it an essential tool for bioconjugation applications in chemical biology research. -
Purine Nucleoside Analog
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine is a purine nucleoside analog with significant potential in cancer therapy. It exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in oncology and cancer treatment development. -
Purine Nucleoside Analog
N1-Cyclopropylmethylpseudouridine is a purine nucleoside analog that exhibits significant antitumor activity, specifically targeting indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on understanding the cellular pathways involved in cancer progression and therapeutic response. -
Purine Nucleoside Analog
9-(2-β-C-Methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. This compound's anticancer mechanisms primarily involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in cancer biology and therapeutic development. Its distinctive structural features allow for exploration in various nucleoside-related studies and therapeutic strategies. -
Purine Nucleoside Analog
N2,2'-O-Dimethylguanosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suited for investigations into therapeutic strategies and the underlying biology of malignant transformation. -
Purine Nucleoside Analog
Alpha-inosine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its therapeutic mechanisms primarily involve the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is useful in research applications focused on cancer biology and the development of novel therapeutic strategies. -
Purine Nucleoside Analog
2'-Deoxy-2'-fluoro-4'-thio-β-D-arabinouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This reagent serves as a valuable tool for researchers investigating novel therapeutic strategies in oncology and elucidating the pathways involved in cancer cell proliferation and survival. -
Purine Nucleoside Analog
6-Amino-9-[2-deoxy-β-D-ribofuranosyl]-9H-purine functions as a purine nucleoside analog. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms are primarily linked to the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in oncology and therapeutic applications targeting cancer cell proliferation. -
Purine Nucleoside Analog
N1-Benzyl pseudouridine is a purine nucleoside analogue that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. The compound operates primarily through the inhibition of DNA synthesis and the induction of apoptosis. Its biological activity makes it a valuable tool for research in cancer biology and the development of therapeutic strategies targeting nucleotide metabolism and tumor proliferation. -
Purine Nucleoside Analog
3’-Azido-3’-deoxy-beta-L-cytidine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its anticancer effects are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as an efficient click chemistry reagent due to its azide functional group, allowing it to engage in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. It is also compatible with strain-promoted alkyne-azide cycloaddition (SPAAC) for reactions involving DBCO or BCN-modified compounds. -
Purine Nucleoside Analog
3,5-Bis-O-(4-methylbenzoyl)-2-C-methyl-D-ribonic acid gamma-lactone is a purine nucleoside analog that exerts significant antitumor activity, particularly against indolent lymphoid malignancies. Its mode of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized effectively in studies aimed at understanding the mechanisms of tumor growth and developing novel therapeutic strategies. -
Purine Nucleoside Analog
5′-Amino-5′-deoxythymidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. This compound functions primarily by inhibiting DNA synthesis and inducing apoptosis, thereby disrupting cancer cell proliferation. It serves as a valuable tool in cancer research and therapeutic applications aimed at understanding and targeting tumorigenic processes. -
Purine Nucleoside Analog
1,2-Di-O-acetyl-3,5-di-O-benzoyl-D-xylofuranose is a purine nucleoside analog that exhibits significant antitumor activity. This compound primarily targets indolent lymphoid malignancies through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. Its potential applications in cancer research include the study of therapeutic strategies aimed at disrupting nucleotide metabolism in tumor cells. -
Purine Nucleoside Analog
3’-Azido-3’-deoxy-5-methyl-beta-L-uridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. Additionally, this compound serves as a versatile click chemistry reagent, featuring an azide group that can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules, such as those with DBCO or BCN moieties. -
Purine Nucleoside Analog
N6-Bz-5'-O-DMTr-2'-O-hexadecanyl adenosine is a purine nucleoside analog that exhibits significant antitumor activity. This compound primarily targets indolent lymphoid malignancies, functioning through mechanisms such as inhibition of DNA synthesis and induction of apoptosis. It serves as a valuable tool for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
Methyl 3'-O-benzyl xyloriboside is a purine nucleoside analog with significant biological activity in inhibiting DNA synthesis and inducing apoptosis. This compound demonstrates broad antitumor effects, particularly in the treatment of indolent lymphoid malignancies. Its mechanisms make it a valuable tool for cancer research and therapeutic investigations. -
Purine Nucleoside Analog
5-Me-3’-dU-2’-phosphoramidite is a purine nucleoside analog designed to inhibit DNA synthesis, contributing to its antitumor activity. This compound demonstrates effectiveness in targeting indolent lymphoid malignancies, mediating cellular apoptosis and disrupting cellular proliferation. Its applications extend to cancer research, particularly in exploring therapeutic strategies against hematological malignancies. -
Purine Nucleoside Analog
7-(3-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action includes the inhibition of DNA synthesis and the induction of apoptosis in cancerous cells. This compound is valuable for research applications focused on cancer biology and therapeutic development for lymphoid cancers. -
Cytidine Analog
4'-C-Methyl-5-methylcytidine is a cytidine nucleoside analog specifically designed to inhibit DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it a valuable tool in cancer research and epigenetic studies. Researchers may utilize this reagent to investigate the role of DNA methylation in gene regulation and the development of therapeutic strategies targeting aberrant methylation patterns.
